United States Sunitinib Malate (CAS?341031-54-7) Market Report 2017

Name: United States Sunitinib Malate (CAS?341031-54-7) Market Report 2017
Brand: QYResearch
SKU: U1E7F6B1A44PEN
Price: 3800 USD
Availability: InStock

October 2017 | 101 pages | ID: U1E7F6B1A44PEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Sunitinib Malate (CAS'341031-54-7) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Sunitinib Malate (CAS'341031-54-7) in these regions, from 2012 to 2022 (forecast).

United States Sunitinib Malate (CAS'341031-54-7) market competition by top manufacturers/players, with Sunitinib Malate (CAS'341031-54-7) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Pfizer Sutent
Topcare pharmaceutical Co., Ltd
Nanjing First Pharmaceutical Co., Ltd.
J&K Scientific
Target Molecule Corp.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Purity: >99%
Purity: >98%
Purity: >97%

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Sunitinib Malate (CAS'341031-54-7) for each application, including

Advanced Kidney Cancer
GIST (Gastrointestinal Stromal Tumor)
Pancreatic Neuroendocrine Tumors

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Sunitinib Malate (CAS?341031-54-7) Market Report 2017

1 SUNITINIB MALATE (CAS?341031-54-7) OVERVIEW

1.1 Product Overview and Scope of Sunitinib Malate (CAS?341031-54-7)
1.2 Classification of Sunitinib Malate (CAS?341031-54-7) by Product Category
  1.2.1 United States Sunitinib Malate (CAS?341031-54-7) Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Sunitinib Malate (CAS?341031-54-7) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Purity: >99%
  1.2.4 Purity: >98%
  1.2.5 Purity: >97%
1.3 United States Sunitinib Malate (CAS?341031-54-7) Market by Application/End Users
  1.3.1 United States Sunitinib Malate (CAS?341031-54-7) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Advanced Kidney Cancer
  1.3.3 GIST (Gastrointestinal Stromal Tumor)
  1.3.4 Pancreatic Neuroendocrine Tumors
1.4 United States Sunitinib Malate (CAS?341031-54-7) Market by Region
  1.4.1 United States Sunitinib Malate (CAS?341031-54-7) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Sunitinib Malate (CAS?341031-54-7) Status and Prospect (2012-2022)
  1.4.3 Southwest Sunitinib Malate (CAS?341031-54-7) Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Sunitinib Malate (CAS?341031-54-7) Status and Prospect (2012-2022)
  1.4.5 New England Sunitinib Malate (CAS?341031-54-7) Status and Prospect (2012-2022)
  1.4.6 The South Sunitinib Malate (CAS?341031-54-7) Status and Prospect (2012-2022)
  1.4.7 The Midwest Sunitinib Malate (CAS?341031-54-7) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Sunitinib Malate (CAS?341031-54-7) (2012-2022)
  1.5.1 United States Sunitinib Malate (CAS?341031-54-7) Sales and Growth Rate (2012-2022)
  1.5.2 United States Sunitinib Malate (CAS?341031-54-7) Revenue and Growth Rate (2012-2022)

2 UNITED STATES SUNITINIB MALATE (CAS?341031-54-7) MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Sunitinib Malate (CAS?341031-54-7) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Sunitinib Malate (CAS?341031-54-7) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Sunitinib Malate (CAS?341031-54-7) Average Price by Players/Suppliers (2012-2017)
2.4 United States Sunitinib Malate (CAS?341031-54-7) Market Competitive Situation and Trends
  2.4.1 United States Sunitinib Malate (CAS?341031-54-7) Market Concentration Rate
  2.4.2 United States Sunitinib Malate (CAS?341031-54-7) Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Sunitinib Malate (CAS?341031-54-7) Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SUNITINIB MALATE (CAS?341031-54-7) SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Sunitinib Malate (CAS?341031-54-7) Sales and Market Share by Region (2012-2017)
3.2 United States Sunitinib Malate (CAS?341031-54-7) Revenue and Market Share by Region (2012-2017)
3.3 United States Sunitinib Malate (CAS?341031-54-7) Price by Region (2012-2017)

4 UNITED STATES SUNITINIB MALATE (CAS?341031-54-7) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Sunitinib Malate (CAS?341031-54-7) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Sunitinib Malate (CAS?341031-54-7) Revenue and Market Share by Type (2012-2017)
4.3 United States Sunitinib Malate (CAS?341031-54-7) Price by Type (2012-2017)
4.4 United States Sunitinib Malate (CAS?341031-54-7) Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SUNITINIB MALATE (CAS?341031-54-7) SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Sunitinib Malate (CAS?341031-54-7) Sales and Market Share by Application (2012-2017)
5.2 United States Sunitinib Malate (CAS?341031-54-7) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SUNITINIB MALATE (CAS?341031-54-7) PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer Sutent
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Sunitinib Malate (CAS?341031-54-7) Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Sutent Sunitinib Malate (CAS?341031-54-7) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Topcare pharmaceutical Co., Ltd
  6.2.2 Sunitinib Malate (CAS?341031-54-7) Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS?341031-54-7) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Nanjing First Pharmaceutical Co., Ltd.
  6.3.2 Sunitinib Malate (CAS?341031-54-7) Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS?341031-54-7) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 J&K Scientific
  6.4.2 Sunitinib Malate (CAS?341031-54-7) Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 J&K Scientific Sunitinib Malate (CAS?341031-54-7) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Target Molecule Corp.
  6.5.2 Sunitinib Malate (CAS?341031-54-7) Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Target Molecule Corp. Sunitinib Malate (CAS?341031-54-7) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 SUNITINIB MALATE (CAS?341031-54-7) MANUFACTURING COST ANALYSIS

7.1 Sunitinib Malate (CAS?341031-54-7) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Sunitinib Malate (CAS?341031-54-7)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Sunitinib Malate (CAS?341031-54-7) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Sunitinib Malate (CAS?341031-54-7) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SUNITINIB MALATE (CAS?341031-54-7) MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Sunitinib Malate (CAS?341031-54-7) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Sunitinib Malate (CAS?341031-54-7) Sales Volume Forecast by Type (2017-2022)
11.3 United States Sunitinib Malate (CAS?341031-54-7) Sales Volume Forecast by Application (2017-2022)
11.4 United States Sunitinib Malate (CAS?341031-54-7) Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Sunitinib Malate (CAS?341031-54-7)
Figure United States Sunitinib Malate (CAS?341031-54-7) Market Size (K MT) by Type (2012-2022)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Volume Market Share by Type (Product Category) in 2016
Figure Purity: >99% Product Picture
Figure Purity: >98% Product Picture
Figure Purity: >97% Product Picture
Figure United States Sunitinib Malate (CAS?341031-54-7) Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Sunitinib Malate (CAS?341031-54-7) by Application in 2016
Figure Advanced Kidney Cancer Examples
Table Key Downstream Customer in Advanced Kidney Cancer
Figure GIST (Gastrointestinal Stromal Tumor) Examples
Table Key Downstream Customer in GIST (Gastrointestinal Stromal Tumor)
Figure Pancreatic Neuroendocrine Tumors Examples
Table Key Downstream Customer in Pancreatic Neuroendocrine Tumors
Figure United States Sunitinib Malate (CAS?341031-54-7) Market Size (Million USD) by Region (2012-2022)
Figure The West Sunitinib Malate (CAS?341031-54-7) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Sunitinib Malate (CAS?341031-54-7) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Sunitinib Malate (CAS?341031-54-7) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Sunitinib Malate (CAS?341031-54-7) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Sunitinib Malate (CAS?341031-54-7) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Sunitinib Malate (CAS?341031-54-7) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales (K MT) and Growth Rate (2012-2022)
Figure United States Sunitinib Malate (CAS?341031-54-7) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Sunitinib Malate (CAS?341031-54-7) Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Sunitinib Malate (CAS?341031-54-7) Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Sunitinib Malate (CAS?341031-54-7) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Sunitinib Malate (CAS?341031-54-7) Sales Share by Players/Suppliers
Figure 2017 United States Sunitinib Malate (CAS?341031-54-7) Sales Share by Players/Suppliers
Figure United States Sunitinib Malate (CAS?341031-54-7) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Sunitinib Malate (CAS?341031-54-7) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Sunitinib Malate (CAS?341031-54-7) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Sunitinib Malate (CAS?341031-54-7) Revenue Share by Players/Suppliers
Figure 2017 United States Sunitinib Malate (CAS?341031-54-7) Revenue Share by Players/Suppliers
Table United States Market Sunitinib Malate (CAS?341031-54-7) Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Sunitinib Malate (CAS?341031-54-7) Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Sunitinib Malate (CAS?341031-54-7) Market Share of Top 3 Players/Suppliers
Figure United States Sunitinib Malate (CAS?341031-54-7) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Sunitinib Malate (CAS?341031-54-7) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Sunitinib Malate (CAS?341031-54-7) Product Category
Table United States Sunitinib Malate (CAS?341031-54-7) Sales (K MT) by Region (2012-2017)
Table United States Sunitinib Malate (CAS?341031-54-7) Sales Share by Region (2012-2017)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Share by Region (2012-2017)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Market Share by Region in 2016
Table United States Sunitinib Malate (CAS?341031-54-7) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Sunitinib Malate (CAS?341031-54-7) Revenue Share by Region (2012-2017)
Figure United States Sunitinib Malate (CAS?341031-54-7) Revenue Market Share by Region (2012-2017)
Figure United States Sunitinib Malate (CAS?341031-54-7) Revenue Market Share by Region in 2016
Table United States Sunitinib Malate (CAS?341031-54-7) Price (USD/MT) by Region (2012-2017)
Table United States Sunitinib Malate (CAS?341031-54-7) Sales (K MT) by Type (2012-2017)
Table United States Sunitinib Malate (CAS?341031-54-7) Sales Share by Type (2012-2017)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Share by Type (2012-2017)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Market Share by Type in 2016
Table United States Sunitinib Malate (CAS?341031-54-7) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Sunitinib Malate (CAS?341031-54-7) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Sunitinib Malate (CAS?341031-54-7) by Type (2012-2017)
Figure Revenue Market Share of Sunitinib Malate (CAS?341031-54-7) by Type in 2016
Table United States Sunitinib Malate (CAS?341031-54-7) Price (USD/MT) by Types (2012-2017)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Growth Rate by Type (2012-2017)
Table United States Sunitinib Malate (CAS?341031-54-7) Sales (K MT) by Application (2012-2017)
Table United States Sunitinib Malate (CAS?341031-54-7) Sales Market Share by Application (2012-2017)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Market Share by Application (2012-2017)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Market Share by Application in 2016
Table United States Sunitinib Malate (CAS?341031-54-7) Sales Growth Rate by Application (2012-2017)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Growth Rate by Application (2012-2017)
Table Pfizer Sutent Basic Information List
Table Pfizer Sutent Sunitinib Malate (CAS?341031-54-7) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Sutent Sunitinib Malate (CAS?341031-54-7) Sales Growth Rate (2012-2017)
Figure Pfizer Sutent Sunitinib Malate (CAS?341031-54-7) Sales Market Share in United States (2012-2017)
Figure Pfizer Sutent Sunitinib Malate (CAS?341031-54-7) Revenue Market Share in United States (2012-2017)
Table Topcare pharmaceutical Co., Ltd Basic Information List
Table Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS?341031-54-7) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS?341031-54-7) Sales Growth Rate (2012-2017)
Figure Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS?341031-54-7) Sales Market Share in United States (2012-2017)
Figure Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS?341031-54-7) Revenue Market Share in United States (2012-2017)
Table Nanjing First Pharmaceutical Co., Ltd. Basic Information List
Table Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS?341031-54-7) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS?341031-54-7) Sales Growth Rate (2012-2017)
Figure Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS?341031-54-7) Sales Market Share in United States (2012-2017)
Figure Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS?341031-54-7) Revenue Market Share in United States (2012-2017)
Table J&K Scientific Basic Information List
Table J&K Scientific Sunitinib Malate (CAS?341031-54-7) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure J&K Scientific Sunitinib Malate (CAS?341031-54-7) Sales Growth Rate (2012-2017)
Figure J&K Scientific Sunitinib Malate (CAS?341031-54-7) Sales Market Share in United States (2012-2017)
Figure J&K Scientific Sunitinib Malate (CAS?341031-54-7) Revenue Market Share in United States (2012-2017)
Table Target Molecule Corp. Basic Information List
Table Target Molecule Corp. Sunitinib Malate (CAS?341031-54-7) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Target Molecule Corp. Sunitinib Malate (CAS?341031-54-7) Sales Growth Rate (2012-2017)
Figure Target Molecule Corp. Sunitinib Malate (CAS?341031-54-7) Sales Market Share in United States (2012-2017)
Figure Target Molecule Corp. Sunitinib Malate (CAS?341031-54-7) Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sunitinib Malate (CAS?341031-54-7)
Figure Manufacturing Process Analysis of Sunitinib Malate (CAS?341031-54-7)
Figure Sunitinib Malate (CAS?341031-54-7) Industrial Chain Analysis
Table Raw Materials Sources of Sunitinib Malate (CAS?341031-54-7) Major Players/Suppliers in 2016
Table Major Buyers of Sunitinib Malate (CAS?341031-54-7)
Table Distributors/Traders List
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Sunitinib Malate (CAS?341031-54-7) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Sunitinib Malate (CAS?341031-54-7) Price (USD/MT) Trend Forecast (2017-2022)
Table United States Sunitinib Malate (CAS?341031-54-7) Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Volume (K MT) Forecast by Type in 2022
Table United States Sunitinib Malate (CAS?341031-54-7) Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Volume (K MT) Forecast by Application in 2022
Table United States Sunitinib Malate (CAS?341031-54-7) Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Sunitinib Malate (CAS?341031-54-7) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Sunitinib Malate (CAS?341031-54-7) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Sunitinib Malate (CAS?341031-54-7) Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports